Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
JLUMHS-Journal of the Liaquat University of Medical Health Sciences. 2017; 16 (1): 49-52
in English | IMEMR | ID: emr-189503

ABSTRACT

Introduction: Myeloid malignancies are clonal disorders of hematopoietic stem/precursor cells. The criteria for the diagnosis of acute myeloid leukemia [AML] are based on morphological cytogenetic and flow-cytometric findings. The prognostic outcome with intensive chemotherapy is better than with non-intensive treatment


Purpose/Objectives: To determine the frequency of various clinical and pathological findings in myeloid malignancies


Study Design: Cross sectional descriptive study


Place and Duration of Study: The study was carried out at Department of Pathology from October 2014 to December 2016


Material/Patients and methods: Detailed history, clinical and pathological findings recorded on a pre-designed proforma including bone marrow reports was evaluated


Results: During period of study, 351 proformas including bone marrow reports were evaluated, from which 49 [30 males and 19 females; age ranges between 03 months to 60 years] were diagnosed as myeloid malignancies. The distribution of myeloid malignancies were acute myeloid leukemia [n=21], chronic myeloid leukemia [n=14], acute myelodysplastic syndrome [n=3], myeloproliferative neoplasms [n=3], myelofibrosis [n=2], myeloid hyperplasia [n=2], acute promyelocytic leukemia [n=2], myelomonocytic leukemia [n=1], ,and transient abnormal myelopoiesis [n=1].The main presenting complaints were fever and weight loss, whereas splenomegaly was the most common finding on clinical examination. The commonest laboratory finding was anemia followed by leukocytosis; while 10 patients showed pancytopenia


Conclusion: AML with fever and bicytopenia is the commonest myeloid malignancy in our series

2.
Annals of King Edward Medical College. 2004; 10 (4): 438-439
in English | IMEMR | ID: emr-175470

ABSTRACT

Sixty subjects were selected and were divided into two groups. Group A included 30 patients of end stage renal disease on regular dialysis and group B included 30 normal healthy subjects as control. Absolute values and Hb were done by hematology auto analyzer and serum and red cell folate were done by commercially available kits. Results were analyzed by using Student`s `t` test and level of significance was done. A significant decreased in serum and red cell folate in end stage renal disease patients with regular dialysis as compared to control

SELECTION OF CITATIONS
SEARCH DETAIL